CY1118286T1 - Μεθοδος και τεχνικο μεσο για τη θεραπευτικη αγωγη φλεγμονωδους νοσου εντερου - Google Patents

Μεθοδος και τεχνικο μεσο για τη θεραπευτικη αγωγη φλεγμονωδους νοσου εντερου

Info

Publication number
CY1118286T1
CY1118286T1 CY20161101171T CY161101171T CY1118286T1 CY 1118286 T1 CY1118286 T1 CY 1118286T1 CY 20161101171 T CY20161101171 T CY 20161101171T CY 161101171 T CY161101171 T CY 161101171T CY 1118286 T1 CY1118286 T1 CY 1118286T1
Authority
CY
Cyprus
Prior art keywords
patient
support material
health care
inflammatory diseases
blood
Prior art date
Application number
CY20161101171T
Other languages
English (en)
Inventor
Magnus Thörn
Ola Winqvist
Original Assignee
Ith Immune Therapy Holdings Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ith Immune Therapy Holdings Ab filed Critical Ith Immune Therapy Holdings Ab
Publication of CY1118286T1 publication Critical patent/CY1118286T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Μέθοδος για τη θεραπευτική αγωγή φλεγμονώδους νόσου εντέρου (IBD) περιλαμβάνει παροχή εντερικού δείγματος βιοψίας, λαμβανόμενου από φλεγμαίνοντα ιστό ενός ασθενούς• κατεργασία με μηχανικό τρόπο του δείγματος για τη λήψη εναιωρήματος κυττάρων• ταυτοποίηση δεικτών κυτταρικής επιφάνειας των ενεργοποιημένων λευκοκυττάρων, επιλεγόμενων από Τ λεμφοκύτταρα, ουδετερόφιλα κοκκιοκύτταρα, και ηωσινόφιλα κοκκιοκύτταρα στο εναιώρημα• ανάπτυξη αντισωμάτων έναντι ενός ή περισσοτέρων εκ των ενεργοποιημένων κυττάρων και ακινητοποίηση αυτών πάνω σε υλικό στήριξης• παροχή στήλης φορτωμένης με το υλικό στήριξης• εκτροπή μεριδίου του περιφερικού αίματος του ασθενούς ώστε να περάσει μέσα από τη στήλη και προτού επανεγχυθεί στον ασθενή ώστε τα ενεργοποιημένα λευκοκύτταρα να συζευχθούν με αντισώματα πάνω στο υλικό στήριξης, εξαλείφοντας έτσι τα από το ρεύμα αίματος. Επίσης αποκαλύπτονται αντίστοιχες στήλες και υλικά στήριξης, και η χρήση τους στη μέθοδο.
CY20161101171T 2006-05-12 2016-11-15 Μεθοδος και τεχνικο μεσο για τη θεραπευτικη αγωγη φλεγμονωδους νοσου εντερου CY1118286T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0601075 2006-05-12
PCT/SE2007/000459 WO2007133147A1 (en) 2006-05-12 2007-05-14 Method and means for treating inflammatory bowel disease

Publications (1)

Publication Number Publication Date
CY1118286T1 true CY1118286T1 (el) 2017-06-28

Family

ID=38694153

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161101171T CY1118286T1 (el) 2006-05-12 2016-11-15 Μεθοδος και τεχνικο μεσο για τη θεραπευτικη αγωγη φλεγμονωδους νοσου εντερου

Country Status (21)

Country Link
US (1) US8449489B2 (el)
EP (1) EP2021025B1 (el)
JP (1) JP5266207B2 (el)
KR (1) KR20090007642A (el)
CN (1) CN101443041A (el)
AU (1) AU2007250552B2 (el)
CA (1) CA2651883C (el)
CY (1) CY1118286T1 (el)
DK (1) DK2021025T3 (el)
EA (1) EA016851B1 (el)
ES (1) ES2603203T3 (el)
HU (1) HUE032241T2 (el)
IL (1) IL195001A0 (el)
LT (1) LT2021025T (el)
NO (1) NO20085180L (el)
PL (1) PL2021025T3 (el)
PT (1) PT2021025T (el)
SG (1) SG171684A1 (el)
SI (1) SI2021025T1 (el)
WO (1) WO2007133147A1 (el)
ZA (1) ZA200809429B (el)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006285446B2 (en) 2005-08-31 2013-08-22 Tla Targeted Immunotherapies Ab Treatment of inflammatory bowel disease
ES2603203T3 (es) 2006-05-12 2017-02-24 Ith Immune Therapy Holdings Ab Método y medio para tratar la enfermedad inflamatoria intestinal
WO2009017444A2 (en) * 2007-08-02 2009-02-05 Iss Immune System Stimulation Ab Diagnosis, staging and monitoring of inflammatory bowel disease
EA023912B1 (ru) * 2008-09-10 2016-07-29 АйТиЭйч ИММЬЮН ТЕРАПИ ХОЛДИНГЗ АБ Лечение воспалительных состояний
US10099227B2 (en) 2009-08-25 2018-10-16 Nanoshell Company, Llc Method and apparatus for continuous removal of sub-micron sized particles in a closed loop liquid flow system
US11285494B2 (en) 2009-08-25 2022-03-29 Nanoshell Company, Llc Method and apparatus for continuous removal of sub-micron sized particles in a closed loop liquid flow system
WO2012099721A2 (en) * 2011-01-18 2012-07-26 The Regents Of The University Of California Real-time adaptive immune system and method
US8979787B2 (en) * 2011-01-20 2015-03-17 Henry John Smith Treatment of pre-eclampsia using targeted apheresis
DK2718313T3 (en) * 2011-06-13 2017-08-28 Tla Targeted Immunotherapies Ab TREATMENT OF RESPIRATORY CONDITIONS
WO2012172345A2 (en) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Treating conditions associated with allergy
US9726666B2 (en) 2011-06-13 2017-08-08 Tla Targeted Immunotherapies Ab Diagnosing and treating inflammatory diseases
WO2012172337A2 (en) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Treating cardiovascular disease
WO2012172343A2 (en) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Treating primary sclerosing cholangitis
WO2012172342A2 (en) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Treating multiple sclerosis
WO2012172339A2 (en) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Treating inflammatory arthritis
EP2718310B1 (en) * 2011-06-13 2017-08-23 TLA Targeted Immunotherapies AB Treating mental disorders
WO2012172336A2 (en) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Treating inflammatory skin diseases
EP2718312B1 (en) * 2011-06-13 2018-07-25 TLA Targeted Immunotherapies AB Treating conditions associated with sepsis
US10073097B2 (en) * 2012-11-28 2018-09-11 Charles C. Caldwell Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome
EP3131558B1 (en) 2014-04-16 2018-11-14 Genovie AB Regulatory t-cells for use in the treatment of inflammatory disorders of the human gastrointestinal tract
WO2015158856A1 (en) * 2014-04-16 2015-10-22 Genovie Ab Cd8+ regulatory t-cells for use in the treatment of inflammatory disorders of the human gastrointestinal tract
WO2021063708A1 (en) * 2019-09-30 2021-04-08 Hemotune Ag Assembly for extracorporeal treatment of body fluids
WO2024122553A1 (ja) * 2022-12-05 2024-06-13 国立大学法人京都大学 潰瘍性大腸炎又は原発性硬化性胆管炎の治療方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS639449A (ja) 1986-07-01 1988-01-16 テルモ株式会社 血液成分分離用器具
JPH0649653B2 (ja) 1988-06-29 1994-06-29 テルモ株式会社 白血球分離材、分離器および分離方法
JPH02167071A (ja) 1988-12-19 1990-06-27 Terumo Corp 非ヒト動物由来白血球系細胞の分離材、分離器および分離方法
JPH0374A (ja) 1988-12-31 1991-01-07 Tonen Corp 白血球吸着分離材
JPH04187206A (ja) 1990-11-19 1992-07-03 Toyobo Co Ltd 白血球分離装置及び白血球分離材料の製造方法
US5728306A (en) 1994-12-23 1998-03-17 Baxter International Inc. Leukodepletion filter and method for filtering leukocytes from freshly drawn blood
DE19538641C2 (de) 1995-10-05 2000-09-21 Privates Inst Bioserv Gmbh Patientenspezifische Immunadsorber für die extrakorporale Apherese und Verfahren für deren Herstellung
JPH1057477A (ja) 1996-08-26 1998-03-03 Asahi Medical Co Ltd 白血球除去フィルター材および白血球除去フィルター装置
JP4197545B2 (ja) * 1997-12-01 2008-12-17 旭化成クラレメディカル株式会社 特異的細胞除去材料
EP1109570B1 (en) * 1998-08-31 2005-10-19 Biogen, Inc. Modulation of memory effector t-cells with a cd2 binding agent
GB0022748D0 (en) * 2000-09-15 2000-11-01 Allied Therapeutics Ltd Reducing the content of cells in a biological sample
JP2003265596A (ja) 2002-03-12 2003-09-24 Asahi Kasei Corp 白血球選択吸着剤及びその評価選択方法
US6936222B2 (en) * 2002-09-13 2005-08-30 Kenneth L. Franco Methods, apparatuses, and applications for compliant membrane blood gas exchangers
US20060234210A1 (en) 2004-04-14 2006-10-19 Affinergy, Inc. Filtration device and method for removing selected materials from biological fluids
DE102005036505A1 (de) 2004-07-30 2006-06-01 Adexter Gmbh Vorrichtung und Verfahren zum Isolieren von Zellen, Biopartikeln und/oder Molekülen aus Flüssigkeiten mit dem Ziel einer Anwendung zur Behandlung von Krankheiten des Menschen
WO2006125201A2 (en) 2005-05-19 2006-11-23 Centocor, Inc. Anti-biotin-pegylated-mcp-1 mutein antibodies, compositions, methods and uses
ES2603203T3 (es) 2006-05-12 2017-02-24 Ith Immune Therapy Holdings Ab Método y medio para tratar la enfermedad inflamatoria intestinal
KR101398768B1 (ko) 2006-09-29 2014-05-27 도레이 카부시키가이샤 세포 흡착 컬럼

Also Published As

Publication number Publication date
PT2021025T (pt) 2016-11-21
ZA200809429B (en) 2009-08-26
SI2021025T1 (sl) 2017-02-28
DK2021025T3 (en) 2016-12-12
EA016851B1 (ru) 2012-08-30
PL2021025T3 (pl) 2017-04-28
IL195001A0 (en) 2011-08-01
CA2651883C (en) 2017-05-30
EP2021025B1 (en) 2016-08-17
EA200802086A1 (ru) 2009-06-30
ES2603203T3 (es) 2017-02-24
HUE032241T2 (en) 2017-09-28
AU2007250552A1 (en) 2007-11-22
US20090192434A1 (en) 2009-07-30
US8449489B2 (en) 2013-05-28
NO20085180L (no) 2008-12-11
LT2021025T (lt) 2017-01-25
EP2021025A4 (en) 2010-08-18
CN101443041A (zh) 2009-05-27
WO2007133147A1 (en) 2007-11-22
SG171684A1 (en) 2011-06-29
AU2007250552B2 (en) 2011-07-07
JP5266207B2 (ja) 2013-08-21
JP2009536944A (ja) 2009-10-22
KR20090007642A (ko) 2009-01-19
CA2651883A1 (en) 2007-11-22
EP2021025A1 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
CY1118286T1 (el) Μεθοδος και τεχνικο μεσο για τη θεραπευτικη αγωγη φλεγμονωδους νοσου εντερου
MX2009003562A (es) Ensayo elisa para la deteccion de vegf.
DE60025526D1 (de) Elisa für vegf
WO2006073682A3 (en) Diagnostic test
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
ATE525648T1 (de) Testelement mit nanofasern
DE60137264D1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
JP2016513094A5 (el)
WO2006085984A3 (en) Immune cell biosensors and methods of using same
ATE461294T1 (de) Brustkrebsdiagnoseverfahren
EA201000131A1 (ru) Диагностика, определение стадии и мониторинг воспалительного заболевания кишечника
ATE550648T1 (de) Adamts4 als blut-biomarker und therapeutisches ziel bei chronischem nierenversagen
JP2022508576A (ja) 電極装備
EA201690004A1 (ru) Антитела против lamp1 и конъюгаты антитела и лекарственного средства, а также их применение
DE60323682D1 (de) Auf hsc70 gerichtete diagnostika und therapeutika für eine gegen mehrere arzneistoffe resistente tumorerkrankung
ATE487947T1 (de) Verfahren zur diagnose und behandlung auf nr2- peptiden beruhender zerebrovaskulärer ereignisse
DE50304586D1 (de) Verfahren zur sepsisdiagnose durch bestimmung von anti-asialo-gangliosid-antikörpern
JP2008526973A5 (el)
JP2016505003A5 (el)
AR029540A1 (es) COMPOSICIONES Y METODOS PARA EL DIAGNoSTICO Y LA TERAPIA DE CA NCER DE PULMoN
BR112022022045A2 (pt) Anticorpo ou fragmento de ligação ao antígeno do mesmo que se liga ao cd103 humano, um ou mais ácidos nucleicos, sistema de expressão, célula hospedeira, composição, métodos de produção de um anticorpo ou fragmento de ligação ao antígeno, para detectar a presença de cd103 em uma amostra biológica, para tratar ou prevenir uma condição mediada por sinalização de cd103 em um indivíduo em necessidade, para inibir a sinalização de cd103 em uma célula, para inibir a ligação de cd103 à e-caderina presente em uma célula, para retirar as células que expressam cd103 em um indivíduo, para tratar ou prevenir uma doença e agente de imageamento
DE602005024690D1 (de) Verfahren und verbindungen zum nachweis von medizinischen erkrankungen
WO2006117681A3 (en) Novel therapies and methods of screening for therapeutic compounds
CY1115197T1 (el) Elisa για vegf
EA200901397A1 (ru) Способ отбора пациента, имеющего заболевание, поддающееся лечению апоптическим агентом